Studies on experimental liver infusion and additional systemic detoxification

This publication has 8 references indexed in Scilit:

• Feasible model for locoregional and systemic longterm administration of drugs and concomitant blood sampling in Sprague-Dawley rats
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1987
• Small cell lung cancer: Results of a phase II study of 1,2,4 triglycidylurazol
  Cancer Chemotherapy and Pharmacology, 1986
• Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2?-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1986
• Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC 332488): A new triepoxide cytostatic agent
  European Journal of Cancer and Clinical Oncology, 1985
• Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)
  Cancer, 1984
• The influence of the protector thiol L-cystein on the toxic and therapeutic responses of stabilized “activated” cyclophosphamide (4-(S-ethanol)-sulfido-cyclophosphamide)
  Investigational New Drugs, 1984
• The analysis and animal pharmacokinetics of 1,2,4, triglycidyl urazol using a high-pressure liquid chromatographic technique
  Cancer Chemotherapy and Pharmacology, 1984
• Protection against the toxicity of alkylating agents by thiols: The mechanism of protection and its relevance to cancer chemotherapy
  European Journal of Cancer (1965), 1966